Information Provided By:
Fly News Breaks for September 8, 2015
HTWR
Sep 8, 2015 | 09:03 EDT
Leerink believes investors are under-appreciating the strategic rationale behind HeartWare's acquisition of Valtech, but admits the all-stock transaction is less than ideal given that it dilutes shareholders by over 25%. The firm lowered its price target for HeartWare to $85 from $110 and keeps an Outperform rating on the name.
News For HTWR From the Last 2 Days
There are no results for your query HTWR